Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:19 PM
Ignite Modification Date:
2025-12-25 @ 2:55 PM
NCT ID:
NCT03792750
Group ID:
EG000
Title:
BMS-986205 in Combination With Nivolumab
Description:
Study treatment starts with a monotherapy therapy 2-week lead-in treatment (Cycle 0) consisting of a single oral daily dose of 100 mg BMS-986205. Followed by combination therapy cycles comprised of an oral daily dose of 100mg BMS-986205 and one dose of 480mg nivolumab administered intravenously Q4W on Day 1 of each treatment cycle up to 12 cycles.
Deaths Number Affected:
3
Deaths Number At Risk:
None
Serious Number Affected:
3
Serious Number At Risk:
12
Other Number Affected:
11
Other Number At Risk:
12
Study:
NCT03792750
Results Section:
NCT03792750
Adverse Events Module:
NCT03792750